The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

dc.contributor.author	Guañabens, Núria
dc.contributor.author	Moro Álvarez, María Jesús
dc.contributor.author	Casado, Enrique
dc.contributor.author	Gómez Alonso, Carlos
dc.contributor.author	SEIOMM Working Group
dc.date.accessioned	2019-08-21T07:34:40Z
dc.date.available	2019-08-21T07:34:40Z
dc.date.issued	2019
dc.identifier.citation	Endocrine, 64(3), p. 441-455 (2019); doi:10.1007/s12020-019-01919-8
dc.identifier.issn	1355-008X
dc.identifier.uri	http://hdl.handle.net/10651/52477
dc.description.statementofresponsibility	Guañabens, N., Moro-Álvarez, M.J., Casado, E., Blanch-Rubió, J., Gómez-Alonso, C., Díaz-Guerra, G.M., del Pino-Montes, J., Díaz de Lamadrid, C.V., Peris, P., Muñoz-Torres, M., SEIOMM Working Group
dc.format.extent	p. 441-455
dc.language.iso	eng
dc.relation.ispartof	Endocrine, 64
dc.rights	© Springer Science+Business Media, LLC, part of Springer Nature 2019
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064466756&doi=10.1007%2fs12020-019-01919-8&partnerID=40&md5=89d822b9414523eb49c5d611366e6ddb
dc.title	The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment
dc.type	journal article
dc.identifier.doi	10.1007/s12020-019-01919-8
dc.relation.publisherversion	http://dx.doi.org/10.1007/s12020-019-01919-8

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.